2,500
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Potential lipase inhibitors from Chinese medicinal herbs

, , , , , , , , , & show all
Pages 2845-2850 | Received 03 Dec 2014, Accepted 29 Apr 2016, Published online: 07 Jun 2016

Figures & data

Table 1. PPL inhibitory activities of various Chinese medicinal herbs.

Figure 1. PPL inhibitory activities of 22 sub-fractions from Panax notoginseng and Magnolia officinalis. Three measurements were carried out per sub-fraction. Data were expressed as an average ± standard deviation (n = 3). The final concentration of the sub-fractions was 200 μg/mL.

Figure 1. PPL inhibitory activities of 22 sub-fractions from Panax notoginseng and Magnolia officinalis. Three measurements were carried out per sub-fraction. Data were expressed as an average ± standard deviation (n = 3). The final concentration of the sub-fractions was 200 μg/mL.

Figure 2. PPL inhibitory activity of 20(S)-ginsenoside Rg3. (a) Chromatograms of (A) reference substance 20(S)-ginsenoside Rg3, (B) mixture sub-fraction PN-17 including (1) ginsenoside Rh4, (2) 20(S)-ginsenoside Rg3, (3) 20(R)-ginsenoside Rg3 at 210 nm. (b) PPL inhibitory activity of three compound components of PN-17. The final concentration of three compound components was 50 μg/mL. (c) Concentration dependent inhibition of PPL by 20(S)-ginsenoside Rg3. The inhibition rate was plotted against the log of the cumulative doses of 20(S)-ginsenoside Rg3 (Mean ± SD, n = 3).

Figure 2. PPL inhibitory activity of 20(S)-ginsenoside Rg3. (a) Chromatograms of (A) reference substance 20(S)-ginsenoside Rg3, (B) mixture sub-fraction PN-17 including (1) ginsenoside Rh4, (2) 20(S)-ginsenoside Rg3, (3) 20(R)-ginsenoside Rg3 at 210 nm. (b) PPL inhibitory activity of three compound components of PN-17. The final concentration of three compound components was 50 μg/mL. (c) Concentration dependent inhibition of PPL by 20(S)-ginsenoside Rg3. The inhibition rate was plotted against the log of the cumulative doses of 20(S)-ginsenoside Rg3 (Mean ± SD, n = 3).

Figure 3. PPL inhibitory activity of honokiol. (a) Chromatograms of (A) reference substance honokiol, (B) sub-fraction MO-19 at 230 nm. (b) The structure of honokiol. (c) Concentration dependent inhibition of PPL by honokiol. The inhibition rate was plotted against the log of the cumulative doses of honokiol (Mean ± SD, n = 3).

Figure 3. PPL inhibitory activity of honokiol. (a) Chromatograms of (A) reference substance honokiol, (B) sub-fraction MO-19 at 230 nm. (b) The structure of honokiol. (c) Concentration dependent inhibition of PPL by honokiol. The inhibition rate was plotted against the log of the cumulative doses of honokiol (Mean ± SD, n = 3).

Table 2. ESI mass analysis of PN-17-2 and MO-19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.